Sanjay Subramanian - 21 Mar 2022 Form 4 Insider Report for Inozyme Pharma, Inc. (INZY)

Role
SVP, CFO
Signature
/s/ Sanjay Subramanian
Issuer symbol
INZY
Transactions as of
21 Mar 2022
Net transactions value
$0
Form type
4
Filing time
22 Mar 2022, 16:11:28 UTC
Previous filing
05 Jan 2022
Next filing
20 Apr 2022
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction INZY Stock option (right to buy) Award $0 +180,000 $0.000000 180,000 21 Mar 2022 Common Stock 180,000 $3.96 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option was granted on March 21, 2022 and is scheduled to vest 25% on the first anniversary of the grant date. The remainder of the shares underlying the option are scheduled to vest in equal monthly installments over the following three years until the fourth anniversary of the grant date.